...
【24h】

Metabolic profiling of GuanXin II prescription based on metabolic fingerprinting and chemical analysis.

机译:基于代谢指纹图谱和化学分析的冠心II处方的代谢谱。

获取原文
获取原文并翻译 | 示例
           

摘要

A sensitive LC/MS method was established to investigate the in vivo metabolism of GuanXin II prescription, a five-component Chinese herbal medicine formulation. Rat plasma, bile, urine, and feces were collected and analyzed following oral administration of the water decoction. A total of 50 compounds were identified, including 17 prototypes and 33 metabolites underwent methylation, oxidation, hydrolysis, sulfate conjugation, glucuronide conjugation, and glutathion conjugation. In addition, the component herb of the formulation from which the metabolites were derived was also identified. Among the five component herbs, Rhizoma Chuanxiong, Flos Carthami, and Lignum Dalbergiae Odoriferae were actively metabolized, contributing 26 metabolites and 2 prototypes, while Radix Salviae Miltiorrhizae and Radix Paeoniae Rubra underwent less biotransformation, yielding 7 metabolites and 15 prototypes. This is the first study on the metabolic profile of GuanXin II prescription. The results could be valuable to elucidate the material basis of this formulated Chinese medicine.
机译:建立了一种敏感的LC / MS方法,以研究冠心II处方(一种五组分中草药制剂)的体内代谢。口服水煎剂后,收集并分析大鼠血浆,胆汁,尿液和粪便。共鉴定出50种化合物,包括17种原型和33种代谢物,进行了甲基化,氧化,水解,硫酸盐结合,葡糖苷酸结合和谷胱甘肽结合。另外,还鉴定了衍生代谢物的制剂的成分药草。在五种成分的草药中,川Rh,弗洛斯·卡塔米和木香黄檀被积极地代谢,贡献了26种代谢物和2种原型,而丹参和丹皮Ru的生物转化较少,产生了7种代谢物和15种原型。这是关于冠心II处方代谢特征的首次研究。该结果对于阐明该中药制剂的物质基础可能是有价值的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号